English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Effect of ether lipids on mouse granulocyte-macrophage progenitor cells.

Vehmeyer, K., Kim, D. J., Nagel, G., Eibl, H. J., & Unger, C. (1989). Effect of ether lipids on mouse granulocyte-macrophage progenitor cells. Cancer Chemotherapy and Pharmacology, 24(1), 58-60. doi:10.1007/BF00254107.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/11858/00-001M-0000-002C-8666-E Version Permalink: http://hdl.handle.net/11858/00-001M-0000-002C-8669-8
Genre: Journal Article

Files

show Files
hide Files
:
2401237.pdf (Publisher version), 307KB
Name:
2401237.pdf
Description:
-
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Locators

show

Creators

show
hide
 Creators:
Vehmeyer, K., Author
Kim, D. J., Author
Nagel, G., Author
Eibl, H. J.1, Author              
Unger, C., Author
Affiliations:
1Department of Membrane Biophysics, MPI for biophysical chemistry, Max Planck Society, ou_578579              

Content

show
hide
Free keywords: -
 Abstract: In this study we determined the potential bone marrow toxicity of the ether lipid derivatives 1-0-octadecyl-2-0-methyl-rac-glycero-3-phosphocholine (OcMe-G-3-PC), 1-0-hexadecyl-propanediol-2-phosphocholine (He-Pr-2-PC), and hexadecylphosphocholine (He-PC). OcMe-G-3-PC inhibited the proliferation of mouse granulocytemacrophage progenitor cells (GM-CFCs) at a dose of 1 μg/ml, whereas He-Pr-2-PC and He-PC started to inhibit the growth of hemopoietic precursors at 5 μg/ml. In contrast to this finding, NMRI mice given 10 mg/kg i.v. daily for 4 weeks and 20 or 30 mg/kg for 5 days showed no bone marrow toxicity. We conclude that the dose-dependent toxic effects observed in vitro are within the physiological tolerance in vivo.

Details

show
hide
Language(s): eng - English
 Dates: 1989-11
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: Peer
 Identifiers: DOI: 10.1007/BF00254107
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Cancer Chemotherapy and Pharmacology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 24 (1) Sequence Number: - Start / End Page: 58 - 60 Identifier: -